Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes
Identifieur interne : 002359 ( Main/Exploration ); précédent : 002358; suivant : 002360Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes
Auteurs : Christina R. Zamzow [Canada] ; Wei Xiong [Canada] ; Fiona E. Parkinson [Canada]Source :
- Journal of Neuroscience Research [ 0360-4012 ] ; 2008-11-15.
English descriptors
- KwdEn :
- Adenosine (metabolism), Animals, Astrocytes (drug effects), Astrocytes (metabolism), Brain (metabolism), Cells, Cultured, Coculture Techniques, Excitatory Amino Acid Agonists (pharmacology), Hypoxanthine (metabolism), N-Methylaspartate (pharmacology), Neurons (drug effects), Neurons (metabolism), Purine-Nucleoside Phosphorylase (metabolism), Rats, Rats, Sprague-Dawley, cocultures, inosine, purine nucleoside phosphorylase, purines.
- MESH :
- chemical , metabolism : Adenosine, Hypoxanthine, Purine-Nucleoside Phosphorylase.
- drug effects : Astrocytes, Neurons.
- metabolism : Astrocytes, Brain, Neurons.
- chemical , pharmacology : Excitatory Amino Acid Agonists, N-Methylaspartate.
- Animals, Cells, Cultured, Coculture Techniques, Rats, Rats, Sprague-Dawley.
Abstract
Adenosine (ADO) is an important neuromodulator in brain. During pathophysiological events such as stroke or brain trauma, ADO levels can increase up to 100‐fold. We tested the hypothesis that astrocytes are important for the removal of ADO produced by neurons and for the metabolism of ADO to inosine (INO) and hypoxanthine (HX). We used four different cell culture preparations: cortical neurons, cortical astrocytes, cocultures of neurons and astrocytes, and neurons transiently cocultured with astrocytes on transwell filters. These cultures were treated with N‐methyl‐D‐aspartate (NMDA), because NMDA receptor activation is a common factor among many causes of neurotoxicity. NMDA significantly increased extracellular ADO, INO, and HX levels from cultured cortical neurons by 3‐, 3.5‐, and 2‐fold, respectively. In cocultures, NMDA significantly increased INO, by 4.5‐fold, and HX, by 3‐fold, but did not increase ADO levels. There was no NMDA‐evoked purine production from astrocytes. Inhibition of purine nucleoside phosphorylase (PNP) significantly decreased HX production from both neurons and cocultures to less than 30% of control levels. The transient addition of astrocytes to neurons during NMDA treatment significantly increased HX and decreased ADO levels compared with neurons alone. In addition, increasing the number of astrocytes was directly correlated with an increased capacity of ADO metabolism to INO and HX. In conclusion, NMDA evoked the production of ADO, INO, and HX from neurons. In the presence of astrocytes, there was significantly less ADO and more HX produced. Thus, ADO produced by neurons is subject to metabolism by astrocytes, a process that may limit its neuromodulatory actions. © 2008 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/jnr.21789
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000168
- to stream Istex, to step Curation: 000168
- to stream Istex, to step Checkpoint: 000964
- to stream PubMed, to step Corpus: 000F33
- to stream PubMed, to step Curation: 000F33
- to stream PubMed, to step Checkpoint: 000F33
- to stream Ncbi, to step Merge: 000936
- to stream Ncbi, to step Curation: 000936
- to stream Ncbi, to step Checkpoint: 000936
- to stream Main, to step Merge: 002554
- to stream Main, to step Curation: 002359
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes</title>
<author><name sortKey="Zamzow, Christina R" sort="Zamzow, Christina R" uniqKey="Zamzow C" first="Christina R." last="Zamzow">Christina R. Zamzow</name>
</author>
<author><name sortKey="Xiong, Wei" sort="Xiong, Wei" uniqKey="Xiong W" first="Wei" last="Xiong">Wei Xiong</name>
</author>
<author><name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5EC3D4461F5974A3CB2A71CC49AADC443A8BB750</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/jnr.21789</idno>
<idno type="url">https://api-v5.istex.fr/document/5EC3D4461F5974A3CB2A71CC49AADC443A8BB750/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000168</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000168</idno>
<idno type="wicri:Area/Istex/Curation">000168</idno>
<idno type="wicri:Area/Istex/Checkpoint">000964</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000964</idno>
<idno type="wicri:doubleKey">0360-4012:2008:Zamzow C:adenosine:produced:by</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18627033</idno>
<idno type="wicri:Area/PubMed/Corpus">000F33</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F33</idno>
<idno type="wicri:Area/PubMed/Curation">000F33</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F33</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F33</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F33</idno>
<idno type="wicri:Area/Ncbi/Merge">000936</idno>
<idno type="wicri:Area/Ncbi/Curation">000936</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000936</idno>
<idno type="wicri:Area/Main/Merge">002554</idno>
<idno type="wicri:Area/Main/Curation">002359</idno>
<idno type="wicri:Area/Main/Exploration">002359</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes</title>
<author><name sortKey="Zamzow, Christina R" sort="Zamzow, Christina R" uniqKey="Zamzow C" first="Christina R." last="Zamzow">Christina R. Zamzow</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName><settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Xiong, Wei" sort="Xiong, Wei" uniqKey="Xiong W" first="Wei" last="Xiong">Wei Xiong</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName><settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName><settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><country>Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, Rm. A402, 753 McDermot Ave., University of Manitoba, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName><settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of Neuroscience Research</title>
<title level="j" type="abbrev">J. Neurosci. Res.</title>
<idno type="ISSN">0360-4012</idno>
<idno type="eISSN">1097-4547</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-11-15">2008-11-15</date>
<biblScope unit="volume">86</biblScope>
<biblScope unit="issue">15</biblScope>
<biblScope unit="page" from="3447">3447</biblScope>
<biblScope unit="page" to="3455">3455</biblScope>
</imprint>
<idno type="ISSN">0360-4012</idno>
</series>
<idno type="istex">5EC3D4461F5974A3CB2A71CC49AADC443A8BB750</idno>
<idno type="DOI">10.1002/jnr.21789</idno>
<idno type="ArticleID">JNR21789</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0360-4012</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine (metabolism)</term>
<term>Animals</term>
<term>Astrocytes (drug effects)</term>
<term>Astrocytes (metabolism)</term>
<term>Brain (metabolism)</term>
<term>Cells, Cultured</term>
<term>Coculture Techniques</term>
<term>Excitatory Amino Acid Agonists (pharmacology)</term>
<term>Hypoxanthine (metabolism)</term>
<term>N-Methylaspartate (pharmacology)</term>
<term>Neurons (drug effects)</term>
<term>Neurons (metabolism)</term>
<term>Purine-Nucleoside Phosphorylase (metabolism)</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
<term>cocultures</term>
<term>inosine</term>
<term>purine nucleoside phosphorylase</term>
<term>purines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Adenosine</term>
<term>Hypoxanthine</term>
<term>Purine-Nucleoside Phosphorylase</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Astrocytes</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Astrocytes</term>
<term>Brain</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Excitatory Amino Acid Agonists</term>
<term>N-Methylaspartate</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cells, Cultured</term>
<term>Coculture Techniques</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Adenosine (ADO) is an important neuromodulator in brain. During pathophysiological events such as stroke or brain trauma, ADO levels can increase up to 100‐fold. We tested the hypothesis that astrocytes are important for the removal of ADO produced by neurons and for the metabolism of ADO to inosine (INO) and hypoxanthine (HX). We used four different cell culture preparations: cortical neurons, cortical astrocytes, cocultures of neurons and astrocytes, and neurons transiently cocultured with astrocytes on transwell filters. These cultures were treated with N‐methyl‐D‐aspartate (NMDA), because NMDA receptor activation is a common factor among many causes of neurotoxicity. NMDA significantly increased extracellular ADO, INO, and HX levels from cultured cortical neurons by 3‐, 3.5‐, and 2‐fold, respectively. In cocultures, NMDA significantly increased INO, by 4.5‐fold, and HX, by 3‐fold, but did not increase ADO levels. There was no NMDA‐evoked purine production from astrocytes. Inhibition of purine nucleoside phosphorylase (PNP) significantly decreased HX production from both neurons and cocultures to less than 30% of control levels. The transient addition of astrocytes to neurons during NMDA treatment significantly increased HX and decreased ADO levels compared with neurons alone. In addition, increasing the number of astrocytes was directly correlated with an increased capacity of ADO metabolism to INO and HX. In conclusion, NMDA evoked the production of ADO, INO, and HX from neurons. In the presence of astrocytes, there was significantly less ADO and more HX produced. Thus, ADO produced by neurons is subject to metabolism by astrocytes, a process that may limit its neuromodulatory actions. © 2008 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Manitoba</li>
</region>
<settlement><li>Winnipeg</li>
</settlement>
<orgName><li>Université du Manitoba</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Manitoba"><name sortKey="Zamzow, Christina R" sort="Zamzow, Christina R" uniqKey="Zamzow C" first="Christina R." last="Zamzow">Christina R. Zamzow</name>
</region>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
<name sortKey="Xiong, Wei" sort="Xiong, Wei" uniqKey="Xiong W" first="Wei" last="Xiong">Wei Xiong</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002359 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002359 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:5EC3D4461F5974A3CB2A71CC49AADC443A8BB750 |texte= Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes }}
This area was generated with Dilib version V0.6.29. |